|
Summary of HCMV-tetramer in HLA-A24 individual groups |
|||||
| Age(yr.) (n = 519) |
0–4 (n = 202) |
5–9 (n = 106) |
10–14 (n = 108) |
15–19 (n = 58) |
20–29 (n = 45) |
|
|
|||||
| Number of tet(+) |
39(19%) |
32(30%) |
23(21%) |
24(41%) |
15(33%) |
| CD8(%) |
20.0 ± 5.7 |
18.6 ± 5.1 |
19.5 ± 6.9 |
22.3 ± 8.3 |
24.8 ± 6.4 |
| Tet(%) |
0.05 ± 0.07 |
0.02 ± 0.03 |
0.02 ± 0.01 |
0.04 ± 0.06 |
0.03 ± 0.03 |
| Tet/CD8(%) |
0.21 ± 0.31 |
0.12 ± 0.10 |
0.15 ± 0.24 |
0.14 ± 0.16 |
0.12 ± 0.10 |
|
HCMV-tetramer positive: Tet/CD8(+) Lymphocytes ≥ 0.04% | |||||
Komatsu et al. Immunity & Ageing 2006 3:11 doi:10.1186/1742-4933-3-11 |
|||||